Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

nalbuphine hydrochloride injection Principal Display Panel

PRINCIPAL DISPLAY PANEL - 1 mL Ampule Label - 1463

NDC 0409-1463-71

1 mL
Rx only

Nalbuphine
HCl Injection 10 mg/mL
For I.V., I.M., or S.C. Use
Protect from light.

Dist. by Hospira, Inc.
Lake Forest, IL 60045 USA

RL-7150

##-###-AA
DMMMYYYY

PRINCIPAL DISPLAY PANEL - 1 mL Ampule Label - 1463

PRINCIPAL DISPLAY PANEL - 1 mL Ampule Tray Label - 1463

1 mL Single-dose 10 Ampuls

Rx only
NDC 0409-1463-01
Contains 10 of NDC 0409-1463-71

Nalbuphine Hydrochloride Injection
10 mg/mL

Protect from light.
Keep ampuls in tray
until time of use.

For Intravenous, Intramuscular, or Subcutaneous Use

Each mL contains nalbuphine HCl 10 mg; sodium citrate, dihydrate 0.47 mg and citric acid,
anhydrous 0.63 mg added as buffers. Sodium chloride added to adjust tonicity. May contain NaOH
and/or HCl for pH adjustment. Usual dosage: See insert. Sterile, nonpyrogenic. Discard unused
portion. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]

RL-7151

LOT ##-###-AA
EXP DMMMYYYY

Distributed by
Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 1 mL Ampule Tray Label - 1463

PRINCIPAL DISPLAY PANEL - 1 mL Ampule Label - 1465

NDC 0409-1465-71

1 mL
Rx only

Nalbuphine
HCl Injection 20 mg/mL
For I.V., I.M., or S.C. Use
Protect from light.

Dist. by Hospira, Inc.
Lake Forest, IL 60045 USA

RL-7155

##-###-AA
DMMMYYYY

PRINCIPAL DISPLAY PANEL - 1 mL Ampule Label - 1465

PRINCIPAL DISPLAY PANEL - 1 mL Ampule Tray Label - 1465

1 mL Single-dose 10 Ampuls

Rx only
NDC 0409-1465-01
Contains 10 of NDC 0409-1465-71

Nalbuphine Hydrochloride Injection
20 mg/mL

Protect from light.
Keep ampuls in tray
until time of use.

For Intravenous, Intramuscular, or Subcutaneous Use

Each mL contains nalbuphine HCl 20 mg; sodium citrate, dihydrate 0.47 mg and citric acid,
anhydrous 0.63 mg added as buffers. Sodium chloride added to adjust tonicity. May contain NaOH
and/or HCl for pH adjustment. Usual dosage: See insert. Sterile, nonpyrogenic. Discard unused
portion. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]

RL-7156

LOT ##-###-AA
EXP DMMMYYYY

Distributed by
Hospira, Inc., Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 1 mL Ampule Tray Label - 1465

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - 1464

NDC 0409-1464-61
Rx only

10 mL Multiple-dose

Nalbuphine
Hydrochloride Injection
100 mg/10 mL (10 mg/mL)

For I.V., I.M., or S.C. Use.

Distributed by Hospira, Inc.
Lake Forest, IL 60045 USA

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - 1464

PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton - 1464

1 x 10 mL
Multiple-dose
Fliptop Vial

NDC 0409-1464-61

Rx only

Nalbuphine
Hydrochloride
Injection
100 mg/10 mL
(10 mg/mL)

For Intravenous,
Intramuscular, or
Subcutaneous Use

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton - 1464

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - 1467

10 mL Multiple-dose

Nalbuphine HCl Injection
200 mg/10 mL (20 mg/mL)

For I.V., I.M., or S.C. Use.

Distributed by Hospira, Inc.
Lake Forest, IL 60045 USA

LOT ##-###-AA
EXP DMMMYYYY

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - 1467

PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton - 1467

10 mL
Multi-dose Fliptop Vial

NDC 0409-1467-61
Rx only

Nalbuphine
Hydrochloride
Injection
200 mg/10 mL
(20 mg/mL)

Protect from light

For Intravenous,
Intramuscular, or
Subcutaneous Use

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton - 1467
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event